Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metformin in the diabetic brain: friend or foe?

Literature DB >> 25333029

Metformin in the diabetic brain: friend or foe?

Paula I Moreira¹.

Abstract

Entities: Chemical Disease

Year: 2014 PMID： 25333029 PMCID： PMC4200667 DOI： 10.3978/j.issn.2305-5839.2014.06.10

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

16 in total

1. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.

Authors: Amit Gupta; Bharti Bisht; Chinmoy Sankar Dey
Journal: Neuropharmacology Date: 2011-01-26 Impact factor: 5.250

2. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.

Authors: Eva Kickstein; Sybille Krauss; Paul Thornhill; Désirée Rutschow; Raphael Zeller; John Sharkey; Ritchie Williamson; Melanie Fuchs; Andrea Köhler; Hartmut Glossmann; Rainer Schneider; Calum Sutherland; Susann Schweiger
Journal: Proc Natl Acad Sci U S A Date: 2010-11-22 Impact factor: 11.205

3. Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance.

Authors: Amanda I Adler; Elizabeth J Shaw; Tim Stokes; Francis Ruiz
Journal: BMJ Date: 2009-05-22

4. Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy.

Authors: Teng Jiang; Jin-Tai Yu; Xi-Chen Zhu; Hui-Fu Wang; Meng-Shan Tan; Lei Cao; Qiao-Quan Zhang; Li Gao; Jian-Quan Shi; Ying-Dong Zhang; Lan Tan
Journal: Br J Pharmacol Date: 2014-07 Impact factor: 8.739

Review 5. Metformin--mode of action and clinical implications for diabetes and cancer.

Authors: Ida Pernicova; Márta Korbonits
Journal: Nat Rev Endocrinol Date: 2014-01-07 Impact factor: 43.330

6. A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin.

Authors: A D McNeilly; R Williamson; D J K Balfour; C A Stewart; C Sutherland
Journal: Diabetologia Date: 2012-08-18 Impact factor: 10.122

7. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.

Authors: Patrick Imfeld; Michael Bodmer; Susan S Jick; Christoph R Meier
Journal: J Am Geriatr Soc Date: 2012-03-28 Impact factor: 5.562

8. Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes.

Authors: Sónia Correia; Cristina Carvalho; Maria S Santos; Teresa Proença; Elsa Nunes; Ana I Duarte; Pedro Monteiro; Raquel Seiça; Catarina R Oliveira; Paula I Moreira
Journal: Med Chem Date: 2008-07 Impact factor: 2.745

9. Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke.

Authors: Venugopal R Venna; Jun Li; Matthew D Hammond; Nickolas S Mancini; Louise D McCullough
Journal: Eur J Neurosci Date: 2014-03-21 Impact factor: 3.386

10. Increased risk of cognitive impairment in patients with diabetes is associated with metformin.

Authors: Eileen M Moore; Alastair G Mander; David Ames; Mark A Kotowicz; Ross P Carne; Henry Brodaty; Michael Woodward; Karyn Boundy; Kathryn A Ellis; Ashley I Bush; Noel G Faux; Ralph Martins; Cassandra Szoeke; Christopher Rowe; David A Watters
Journal: Diabetes Care Date: 2013-09-05 Impact factor: 19.112

13 in total

1. Metformin: historical overview.

Authors: Clifford J Bailey
Journal: Diabetologia Date: 2017-08-03 Impact factor: 10.122

Review 2. Metformin and ageing: improving ageing outcomes beyond glycaemic control.

Authors: Willy Marcos Valencia; Ana Palacio; Leonardo Tamariz; Hermes Florez
Journal: Diabetologia Date: 2017-08-02 Impact factor: 10.122

Review 3. Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.

Authors: Emanuel Monteiro Candeias; Inês Carolina Sebastião; Susana Maria Cardoso; Sónia Catarina Correia; Cristina Isabel Carvalho; Ana Isabel Plácido; Maria Sancha Santos; Catarina Resende Oliveira; Paula Isabel Moreira; Ana Isabel Duarte
Journal: World J Diabetes Date: 2015-06-25

4. Obligatory role of endoplasmic reticulum in brain FDG uptake.

Authors: Vanessa Cossu; Cecilia Marini; Patrizia Piccioli; Anna Rocchi; Silvia Bruno; Anna Maria Orengo; Laura Emionite; Matteo Bauckneht; Federica Grillo; Selene Capitanio; Enrica Balza; Nikola Yosifov; Patrizia Castellani; Giacomo Caviglia; Isabella Panfoli; Silvia Morbelli; Silvia Ravera; Fabio Benfenati; Gianmario Sambuceti
Journal: Eur J Nucl Med Mol Imaging Date: 2019-01-08 Impact factor: 9.236

Review 5. Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.

Authors: Roni Manyevitch; Matthew Protas; Sean Scarpiello; Marisa Deliso; Brittany Bass; Anthony Nanajian; Matthew Chang; Stefani M Thompson; Neil Khoury; Rachel Gonnella; Margit Trotz; D Blaine Moore; Emily Harms; George Perry; Lucy Clunes; Angelica Ortiz; Jan O Friedrich; Ian V J Murray
Journal: Curr Alzheimer Res Date: 2018 Impact factor: 3.498

Review 6. Sweet Mitochondria: A Shortcut to Alzheimer's Disease.

Authors: Paula I Moreira
Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472

7. Streptozotocin-induced β-cell damage, high fat diet, and metformin administration regulate Hes3 expression in the adult mouse brain.

Authors: Polyxeni Nikolakopoulou; Antonios Chatzigeorgiou; Ioannis Kourtzelis; Louiza Toutouna; Jimmy Masjkur; Carina Arps-Forker; Steven W Poser; Jan Rozman; Birgit Rathkolb; Juan Antonio Aguilar-Pimentel; Eckhard Wolf; Martin Klingenspor; Markus Ollert; Carsten Schmidt-Weber; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Vasiliki Tsata; Laura Sebastian Monasor; Maria Troullinaki; Anke Witt; Vivian Anastasiou; George Chrousos; Chun-Xia Yi; Cristina García-Cáceres; Matthias H Tschöp; Stefan R Bornstein; Andreas Androutsellis-Theotokis
Journal: Sci Rep Date: 2018-07-27 Impact factor: 4.379